SCHEMBL4190959

SCHEMBL4190959

O=C(O)CCC(=O)c1cccc(O)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 1/20 0.64
CA12 O43570 1/20 0.59
CA1 P00915 1/20 0.59
CA2 P00918 1/20 0.59
CA6 P23280 1/20 0.59
CA9 Q16790 1/20 0.59
ALDH1A1 P00352 3/20 0.58
CYP2C19 P33261 2/20 0.58
GAA P10253 1/20 0.58
CTNNB1 P35222 1/20 0.58
PARP1 P09874 1/20 0.52
CYP1A2 P05177 3/20 0.52
KDM4E B2RXH2 2/20 0.52
FFAR1 O14842 1/20 0.52
LMNA P02545 1/20 0.52
RAB9A P51151 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
HIF1A Q16665 1/20 0.52
EGLN2 Q96KS0 1/20 0.48
KMT2A Q03164 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30666338 1.00 NR4A2 (0.64) NR4A2CA12CA1CA2CA6
SCHEMBL4186280 0.89 HDAC3 (0.59) NR4A2CA12CA1CA2CA6
SCHEMBL3943135 0.89 HDAC1 (0.65) NR4A2CA12CA1CA2CA6
Succinic Acid SCHEMBL8655758 0.83 ALDH1A1 (0.60) NR4A2CA12CA1CA2CA6
SCHEMBL14277039 0.83 PARP1 (0.60) NR4A2CA12CA1CA2CA6
SCHEMBL4569137 0.82 PARP1 (0.59) CA12CA1CA2CA6CA9
SCHEMBL2979252 0.82 KDM4E (0.59) CA12CA1CA2CA6CA9
SCHEMBL7668492 0.82 CA12 (0.61) CA12CA1CA2CA6CA9
SCHEMBL8535224 0.81 SMN1; SMN2 (0.72) NR4A2ALDH1A1CYP2C19GAACYP1A2
SCHEMBL2026598 0.81 HSD17B3 (0.60) CA12CA1CA2CA6CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109675550-B Molybdenum-boron/sepiolite catalyst and preparation method and application thereof 安徽理工大学 2021-10-26 CN claimed
CN-109369367-B Method for preparing 4- (3-hydroxyphenyl) -4-oxobutyric acid from lignin 安徽理工大学 2021-01-15 CN claimed
CN-109369367-A A kind of lignin prepares 4-(3- hydroxy phenyl) method of -4- ketobutyric acid 安徽理工大学 2019-02-22 CN claimed
CN-109675550-B Molybdenum-boron/sepiolite catalyst and preparation method and application thereof 安徽理工大学 2021-10-26 CN disclosed
CN-109369367-B Method for preparing 4- (3-hydroxyphenyl) -4-oxobutyric acid from lignin 安徽理工大学 2021-01-15 CN disclosed
CN-109369367-B Method for preparing 4- (3-hydroxyphenyl) -4-oxobutyric acid from lignin 安徽理工大学 2021-01-15 CN disclosed
CN-109369367-B Method for preparing 4- (3-hydroxyphenyl) -4-oxobutyric acid from lignin 安徽理工大学 2021-01-15 CN disclosed
CN-109675550-A A kind of molybdenum-boron/sepiolite catalyst and its preparation method and application 安徽理工大学 2019-04-26 CN disclosed
CN-109369367-A A kind of lignin prepares 4-(3- hydroxy phenyl) method of -4- ketobutyric acid 安徽理工大学 2019-02-22 CN disclosed
CN-109369367-A A kind of lignin prepares 4-(3- hydroxy phenyl) method of -4- ketobutyric acid 安徽理工大学 2019-02-22 CN disclosed
EP-2023930-A1 IONIZABLE INHIBITORS OF FATTY ACID AMIDE HYDROLASE N.V. Organon (NL) 2009-02-18 EP disclosed
WO-2008020866-A1 IONIZABLE INHIBITORS OF FATTY ACID AMIDE HYDROLASE N.V. ORGANON 2008-02-21 WO disclosed
US-20070155707-A1 IONIZABLE INHIBITORS OF FATTY ACID AMIDE HYDROLASE KADMUS PHARMACEUTICALS, INC. (US) 2007-07-05 US disclosed
US-4082843-A 3-(3-(3-Substituted amino-2-hydroxypropoxy)phenyl)-6-hydrazino pyridazines and their use as vasodilators and β-adrenergic blocking agents SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1978-04-04 US disclosed
US-4058529-A Polycyclic amino derivatives of pyrrolidone and piperidone CIBA-GEIGY CORPORATION (US) 1977-11-15 US disclosed
US-4011321-A 6-(3-SUBSTITUTED AMINO-2-HYDROXYPROPOXYARYL)-4,5-DIHYDRO-3(2H)-PYRIDAZINONES SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1977-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155707-A1 IONIZABLE INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, NAAA NR4A2 3076/4885CA12 1457/4885CA1 229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.